16-28491759-T-G

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate

The NM_001286110.2(CLN3):​c.-83A>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

CLN3
NM_001286110.2 5_prime_UTR_premature_start_codon_gain

Scores

8
3
4

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 2.17

Publications

6 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.987
PP5
Variant 16-28491759-T-G is Pathogenic according to our data. Variant chr16-28491759-T-G is described in ClinVar as Pathogenic. ClinVar VariationId is 56257.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001286110.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
NM_001042432.2
MANE Select
c.1A>Cp.Met1?
initiator_codon
Exon 2 of 16NP_001035897.1Q13286-1
CLN3
NM_001286110.2
c.-83A>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 14NP_001273039.1B4DFF3
CLN3
NM_001286109.2
c.-83A>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 14NP_001273038.1Q2TA70

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
ENST00000636228.1
TSL:1
c.-83A>C
5_prime_UTR_premature_start_codon_gain
Exon 1 of 13ENSP00000489627.1O95086
CLN3
ENST00000636147.2
TSL:1 MANE Select
c.1A>Cp.Met1?
initiator_codon
Exon 2 of 16ENSP00000490105.1Q13286-1
CLN3
ENST00000359984.12
TSL:1
c.1A>Cp.Met1?
initiator_codon
Exon 1 of 15ENSP00000353073.9Q13286-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461554
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33468
American (AMR)
AF:
0.00
AC:
0
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5572
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111998
Other (OTH)
AF:
0.00
AC:
0
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Neuronal ceroid lipofuscinosis (1)
1
-
-
Neuronal ceroid lipofuscinosis 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.50
CADD
Uncertain
23
DANN
Benign
0.95
DEOGEN2
Benign
0.20
T
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.97
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.99
D
PhyloP100
2.2
PROVEAN
Benign
-0.63
N
REVEL
Pathogenic
0.67
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.73
P
Vest4
0.73
MutPred
1.0
Loss of MoRF binding (P = 0.0739)
MVP
0.91
ClinPred
1.0
D
GERP RS
4.8
PromoterAI
-0.042
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.87
gMVP
0.29
Mutation Taster
=3/197
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs386833708; hg19: chr16-28503080; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.